Connected Smart Pen Cap and Glycaemic Control Research Title Analysis of Glycaemic Control and Treatment Satisfaction with a Connected Smart Pen Cap in Adults with Type 1 Diabetes: A Randomised, Open-Label, Parallel-Group Trial Journal Diabetologia, May 2026 Research Focus Evaluates the effectiveness of connected insulin pen caps in improving glycaemic control and treatment satisfaction. Key Findings The trial included 42 participants. Connected pen caps reduced time spent in severe hyperglycaemia and glucose variability compared with non-connected caps. The study also reported reduced hypoglycaemia avoidance behaviours. Source PubMed – PMID: 41634174 Connected Insulin Cap and Injection Timing Research Title Improvement in Insulin Injection Timing and Glucometrics Using a Connected Insulin Cap: The Insulclock v2.0 Prospective Study Journal Frontiers in Endocrinology, July 2026 Research Focus Examines the impact of connected insulin pen caps on injection timing, insulin adherence, and glucose management. Key Findings Among 52 participants completing the study, time in range improved from 56.9% to 61.9%, while on-time insulin injections increased from 45.5% to 54.4% during the active monitoring phase. Source PubMed – PMID: 42528822 Smart Insulin Pens Versus Automated Insulin Delivery Research Title Technology Choice, Glycemic Control and Patient-Reported Outcome Measures in Adults with Type 1 Diabetes: A Randomized Crossover Trial Comparing a Smart Insulin Pen with an Automated Insulin Delivery System (EBIACE-1) Journal Diabetes Research and Clinical Practice, September 2026 Research Focus Compares smart insulin pens with automated insulin delivery systems in adults with type 1 diabetes. Key Findings The study involved 31 adults. Automated insulin delivery achieved higher time in range (81% versus 66%), although 46% of participants achieved near-optimal glycaemic control using smart insulin pens. Source PubMed – PMID: 42612915 Efficacy and Safety of Connected Insulin Pens Research Title Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol (SMART-5 Study) Journal Endocrinology and Metabolism, June 2026 Research Focus Investigates advanced connected insulin pens incorporating continuous glucose monitoring, individualized dose recommendations, and digital coaching. Key Findings The study protocol outlines a randomized trial involving 152 participants. It will evaluate whether advanced connected insulin pens improve HbA1c compared with conventional tracking insulin pens. Results are not yet established by this protocol. Source PubMed – PMID: 41391451 Dose Accuracy of Connected Insulin Pens Research Title Dose Accuracy and Reliability of a Connected Insulin Pen System Journal Journal of Diabetes Science and Technology, March 2026 issue Research Focus Evaluates dose accuracy, reliability, and data transmission capabilities of the Tempo connected insulin pen system. Key Findings The system met ISO 11608-1:2014 dose-accuracy requirements across three tested dose levels. Its connected module also reliably detected, stored, and transmitted insulin dosing information. Source PubMed – PMID: 39881439 Share this article